Abpro is a biotechnology company focused on therapeutics, diagnostics, and research.
Sign up today and learn more about Abpro Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Abpro Stock
Abpro is a biotechnology company dedicated to accelerating biological research by providing superior tools to researchers worldwide. As a pioneer of industrial biochemistry and an emerging leader in the reagents field, they have developed a proprietary technology platform that allows for faster, more efficient production of recombinant proteins and antibodies. As a result, Abpro delivers superior quality products at industry-leading speeds. Abpro leveraging these platforms, both independently and through collaborations with global pharmaceutical companies and research institutions to develop therapeutic antibodies for use in immuno-oncology, ophthalmology, and other disease areas. The DiversImmune platform enables the generation of novel antibodies and next-generation antibody therapies.
CEO & CO-FOUNDER
SVP OF STRATEGIC ALLIANCES
Chairman & CEO
CMO & SVP
Robert J. Markelewicz